These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 11058158)
1. Neuronal death enhanced by N-methyl-D-aspartate antagonists. Ikonomidou C; Stefovska V; Turski L Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12885-90. PubMed ID: 11058158 [TBL] [Abstract][Full Text] [Related]
2. Long-term effects of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate and 6-nitro-7-sulphamoylbenzo(f)quinoxaline-2,3-dione in the rat basal ganglia: calcification, changes in glutamate receptors and glial reactions. Petegnief V; Saura J; Dewar D; Cummins DJ; Dragunow M; Mahy N Neuroscience; 1999; 94(1):105-15. PubMed ID: 10613501 [TBL] [Abstract][Full Text] [Related]
3. N-methyl-D-aspartate receptor-mediated mitochondrial Ca(2+) overload in acute excitotoxic motor neuron death: a mechanism distinct from chronic neurotoxicity after Ca(2+) influx. Urushitani M; Nakamizo T; Inoue R; Sawada H; Kihara T; Honda K; Akaike A; Shimohama S J Neurosci Res; 2001 Mar; 63(5):377-87. PubMed ID: 11223912 [TBL] [Abstract][Full Text] [Related]
5. Lowered brain stimulation reward thresholds in rats treated with a combination of caffeine and N-methyl-D-aspartate but not alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate or metabotropic glutamate receptor-5 receptor antagonists. Bespalov A; Dravolina O; Belozertseva I; Adamcio B; Zvartau E Behav Pharmacol; 2006 Jun; 17(4):295-302. PubMed ID: 16914947 [TBL] [Abstract][Full Text] [Related]
6. Group II metabotropic and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate glutamate receptors regulate the deficit in brain reward function associated with nicotine withdrawal in rats. Kenny PJ; Gasparini F; Markou A J Pharmacol Exp Ther; 2003 Sep; 306(3):1068-76. PubMed ID: 12805481 [TBL] [Abstract][Full Text] [Related]
7. mGluR5 antagonists 2-methyl-6-(phenylethynyl)-pyridine and (E)-2-methyl-6-(2-phenylethenyl)-pyridine reduce traumatic neuronal injury in vitro and in vivo by antagonizing N-methyl-D-aspartate receptors. Movsesyan VA; O'Leary DM; Fan L; Bao W; Mullins PG; Knoblach SM; Faden AI J Pharmacol Exp Ther; 2001 Jan; 296(1):41-7. PubMed ID: 11123360 [TBL] [Abstract][Full Text] [Related]
8. Traumatic brain damage prevented by the non-N-methyl-D-aspartate antagonist 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo[f] quinoxaline. Bernert H; Turski L Proc Natl Acad Sci U S A; 1996 May; 93(11):5235-40. PubMed ID: 8643559 [TBL] [Abstract][Full Text] [Related]
10. Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors. Lea PM; Movsesyan VA; Faden AI Br J Pharmacol; 2005 Jun; 145(4):527-34. PubMed ID: 15821750 [TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effects of mebudipine and dibudipine on cerebral oxygen-glucose deprivation/reperfusion injury. Tavakoli-Far B; Rahbar-Roshandel N; Rahimi-Moghaddam P; Mahmoudian M Eur J Pharmacol; 2009 May; 610(1-3):12-7. PubMed ID: 19285496 [TBL] [Abstract][Full Text] [Related]
12. Selective blockade of the mGluR1 receptor reduces traumatic neuronal injury in vitro and improvesoOutcome after brain trauma. Faden AI; O'Leary DM; Fan L; Bao W; Mullins PG; Movsesyan VA Exp Neurol; 2001 Feb; 167(2):435-44. PubMed ID: 11161632 [TBL] [Abstract][Full Text] [Related]
13. Determination of intracellular Ca2+ concentration can be a useful tool to predict neuronal damage and neuroprotective properties of drugs. Ferger D; Krieglstein J Brain Res; 1996 Sep; 732(1-2):87-94. PubMed ID: 8891272 [TBL] [Abstract][Full Text] [Related]
14. Isoflurane preconditioning decreases glutamate receptor overactivation-induced Purkinje neuronal injury in rat cerebellar slices. Zheng S; Zuo Z Brain Res; 2005 Aug; 1054(2):143-51. PubMed ID: 16081051 [TBL] [Abstract][Full Text] [Related]
15. Effect of glutamate receptor antagonists on N-methyl-D-aspartate- and (S)-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-induced convulsant effects in mice and rats. Bisaga A; Krzascik P; Jankowska E; Palejko W; Kostowski W; Danysz W Eur J Pharmacol; 1993 Oct; 242(3):213-20. PubMed ID: 7506658 [TBL] [Abstract][Full Text] [Related]
16. Small-molecule inhibitors at the PSD-95/nNOS interface protect against glutamate-induced neuronal atrophy in primary cortical neurons. Doucet MV; O'Toole E; Connor T; Harkin A Neuroscience; 2015 Aug; 301():421-38. PubMed ID: 26071957 [TBL] [Abstract][Full Text] [Related]
17. Glutamate, NMDA, and AMPA induced changes in extracellular space volume and tortuosity in the rat spinal cord. Vargová L; Jendelová P; Chvátal A; Syková E J Cereb Blood Flow Metab; 2001 Sep; 21(9):1077-89. PubMed ID: 11524612 [TBL] [Abstract][Full Text] [Related]
18. 3-Nitropropionic acid toxicity in hippocampus: protection through N-methyl-D-aspartate receptor antagonism. Karanian DA; Baude AS; Brown QB; Parsons CG; Bahr BA Hippocampus; 2006; 16(10):834-42. PubMed ID: 16897723 [TBL] [Abstract][Full Text] [Related]
19. Neuroprotective strategies for treatment of lesions produced by mitochondrial toxins: implications for neurodegenerative diseases. Schulz JB; Matthews RT; Henshaw DR; Beal MF Neuroscience; 1996 Apr; 71(4):1043-8. PubMed ID: 8684608 [TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships in a series of 2(1H)-quinolones bearing different acidic function in the 3-position: 6,7-dichloro-2(1H)-oxoquinoline-3-phosphonic acid, a new potent and selective AMPA/kainate antagonist with neuroprotective properties. Desos P; Lepagnol JM; Morain P; Lestage P; Cordi AA J Med Chem; 1996 Jan; 39(1):197-206. PubMed ID: 8568808 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]